DE69233330D1 - Verwendung eines Inhibitors von Tau/Neurofilament-Proteinkinase PK40 - Google Patents

Verwendung eines Inhibitors von Tau/Neurofilament-Proteinkinase PK40

Info

Publication number
DE69233330D1
DE69233330D1 DE69233330T DE69233330T DE69233330D1 DE 69233330 D1 DE69233330 D1 DE 69233330D1 DE 69233330 T DE69233330 T DE 69233330T DE 69233330 T DE69233330 T DE 69233330T DE 69233330 D1 DE69233330 D1 DE 69233330D1
Authority
DE
Germany
Prior art keywords
kinases
tau
inhibitor
protein kinase
neurofilament protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69233330T
Other languages
English (en)
Other versions
DE69233330T2 (de
Inventor
M Ingram
Hanno M Roder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Application granted granted Critical
Publication of DE69233330D1 publication Critical patent/DE69233330D1/de
Publication of DE69233330T2 publication Critical patent/DE69233330T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10345—Special targeting system for viral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Virology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
DE69233330T 1991-08-09 1992-07-10 Verwendung eines inhibitors der tau/neurofilament proteinkinase pk40 Expired - Fee Related DE69233330T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74288091A 1991-08-09 1991-08-09
US742880 1991-08-09

Publications (2)

Publication Number Publication Date
DE69233330D1 true DE69233330D1 (de) 2004-04-29
DE69233330T2 DE69233330T2 (de) 2005-03-10

Family

ID=24986618

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69232121T Expired - Fee Related DE69232121T2 (de) 1991-08-09 1992-07-10 Verwendungen einer proteinkinase von ton und neurofilament pk40
DE69233330T Expired - Fee Related DE69233330T2 (de) 1991-08-09 1992-07-10 Verwendung eines inhibitors der tau/neurofilament proteinkinase pk40

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69232121T Expired - Fee Related DE69232121T2 (de) 1991-08-09 1992-07-10 Verwendungen einer proteinkinase von ton und neurofilament pk40

Country Status (9)

Country Link
EP (2) EP1026237B1 (de)
JP (1) JPH06510427A (de)
AT (2) ATE206755T1 (de)
AU (1) AU675410B2 (de)
CA (1) CA2115151C (de)
DE (2) DE69232121T2 (de)
DK (2) DK0667898T3 (de)
ES (2) ES2216745T3 (de)
WO (1) WO1993003148A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7408027B1 (en) 1991-12-06 2008-08-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenchaften Tools for the diagnosis and treatment of Alzheimer's disease
DK0618968T3 (da) * 1991-12-06 2000-04-10 Max Planck Gesellschaft Midler til diagnostisering og behandling af Alzheimer's sygdom
JPH07506969A (ja) * 1992-05-11 1995-08-03 ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ レセプタ型チロシンキナーゼ類似の分子
US6013646A (en) * 1998-07-02 2000-01-11 Bayer Corporation Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer
CA2415762A1 (en) * 2000-07-07 2002-01-17 Milliken & Company Textile substrates having durable water repellency and soil release and method for producing same
CN101084204B (zh) 2004-09-23 2012-12-05 卫思道制药有限公司 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法
RU2639537C2 (ru) * 2011-10-07 2017-12-21 Ац Иммуне С.А. Фосфоспецифичные антитела, распознающие тау

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004032A1 (en) * 1989-09-15 1991-04-04 Gensia Pharmaceuticals, Inc. Methods of treating neurodegenerative conditions
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
WO1993003177A1 (en) * 1991-08-09 1993-02-18 Massachusetts Institute Of Technology Novel tau/neurofilament protein kinases
EP0544942A1 (de) * 1991-12-06 1993-06-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Neue Werkzeuge für die Diagnose und die Behandlung der Alzheimer-Krankheit

Also Published As

Publication number Publication date
DE69232121T2 (de) 2002-06-20
AU675410B2 (en) 1997-02-06
DK0667898T3 (da) 2002-02-04
EP1026237A2 (de) 2000-08-09
EP0667898B1 (de) 2001-10-10
DE69233330T2 (de) 2005-03-10
ATE206755T1 (de) 2001-10-15
DK1026237T3 (da) 2004-07-19
ES2165358T3 (es) 2002-03-16
AU2324092A (en) 1993-03-02
CA2115151C (en) 2005-05-17
EP0667898A1 (de) 1995-08-23
WO1993003148A3 (en) 1993-04-01
CA2115151A1 (en) 1993-02-18
DE69232121D1 (de) 2001-11-15
ATE262584T1 (de) 2004-04-15
WO1993003148A2 (en) 1993-02-18
EP1026237B1 (de) 2004-03-24
ES2216745T3 (es) 2004-11-01
JPH06510427A (ja) 1994-11-24
EP1026237A3 (de) 2001-03-28

Similar Documents

Publication Publication Date Title
ATE299145T1 (de) Neues multimerisierendes reagenz
DE69232907D1 (de) Neue heterocyclische/cyclische amine
DE69128516T2 (de) Neue Mercaptoacetylamid-Derivate zur Verwendung als Enkephalinase- und ACE-Hemmer
DE10299011I1 (de) Interleukin-1-Inhibitoren
DK415089D0 (da) Fremgangsmaade til suspensionspolymerisation i et organisk medium
ES2190430T3 (es) Nuevas sulfonamidas.
FI96204C (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
DE69529849T2 (de) Biphenyl-2-carbonsäure-tetrahydro-isochinolin-6-yl amid derivate, deren hestellung und deren verwendung als inhibitoren des mikrosomalen triglycerid-transfer-proteins und/oder der apolipoprotein b (apo b) sekretion
EA199700087A1 (ru) Способ ингибирования катепсина к
PT83535B (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de aminoacidos
DE69233330D1 (de) Verwendung eines Inhibitors von Tau/Neurofilament-Proteinkinase PK40
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
DE3689853D1 (de) Verwendung von Gyrasehemmern zur Dekontamination von Mycoplasma-infizierten Zellkulturen.
DE69625910D1 (de) Penamsulfone als beta-laktamase inhibitoren
DE3851979D1 (de) Substituierte Vinylcephalosporine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
DE69206001D1 (de) Verfahren zur hochsensitiven Bestimmung von NADH mit NADH Kinase.
NO305556B1 (no) Tiokarbamoylforbindelser og anvendelse derav samt middel for beskyttelse av tekniske materialer
ATE57704T1 (de) Heterocyclische pentalenderivate zur verwendung bei der bekaempfung von mikroorganismen.
MX9700116A (es) Uso de leucotriarilmetanos para la marcacion de hidrocarburos.
DE68903268T2 (de) Verwendung von folinsaeurederivaten als plaettchenaggregationshemmstoffe.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee